Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
7,872,317
-
Share change
-
-35,725
-
Total reported value
-
$21,841,913
-
Put/Call ratio
-
133%
-
Price per share
-
$2.77
-
Number of holders
-
81
-
Value change
-
-$777,544
-
Number of buys
-
44
-
Number of sells
-
30
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q1 2025
As of 31 Mar 2025,
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,872,317 shares.
The largest 10 holders included
MILLENNIUM MANAGEMENT LLC, BlackRock, Inc., UBS Group AG, GSA CAPITAL PARTNERS LLP, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, GOLDMAN SACHS GROUP INC, DEUTSCHE BANK AG\, BNP PARIBAS FINANCIAL MARKETS, GEODE CAPITAL MANAGEMENT, LLC, and Swiss National Bank.
This page lists
81
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.